"Surface epithelial slackening" pattern in endometrioid carcinoma: A morphological feature for differentiating the POLE mutation-subtype from the no specific molecular profile subtype.

[1]  Gong Yang,et al.  Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer , 2022, Frontiers in Oncology.

[2]  E. Lucas,et al.  Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features. , 2022, Seminars in diagnostic pathology.

[3]  A. Tanimoto,et al.  Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel , 2021, Pathology & Oncology Research.

[4]  A. Tanimoto,et al.  ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma , 2021, Pathology - Research and Practice.

[5]  T. Kondo,et al.  Expressions of IL-8 and CXCL5 in uterine endometrioid carcinomas which have frequent neutrophil infiltration and comparison to colorectal adenocarcinoma. , 2020, Histology and histopathology.

[6]  Y. Li,et al.  Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. , 2020, Pathology.

[7]  Shinsuke Suzuki,et al.  Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens , 2020, BMC Medical Genomics.

[8]  T. Bosse,et al.  Incorporation of molecular characteristics into endometrial cancer management , 2019, Histopathology.

[9]  C. Gilks,et al.  Interpretation of somatic POLE mutations in endometrial carcinoma , 2019, The Journal of pathology.

[10]  C. Gilks,et al.  Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas , 2019, The Journal of pathology.

[11]  J. Delotte,et al.  Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma , 2019, Cancer Microenvironment.

[12]  Ira M. Hall,et al.  Genomic Analysis in the Age of Human Genome Sequencing , 2019, Cell.

[13]  C. Gilks,et al.  High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[14]  A. Talhouk,et al.  Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Zhong Wu,et al.  smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers , 2018, bioRxiv.

[16]  J. Goeman,et al.  Blinded histopathological characterisation of POLE exonuclease domain‐mutant endometrial cancers: sheep in wolf's clothing , 2018, Histopathology.

[17]  W. Weichert,et al.  Universal Genomic Testing: The next step in oncological decision-making or a dead end street? , 2017, European journal of cancer.

[18]  A. Talhouk,et al.  Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer , 2017, Cancer.

[19]  Peter Horak,et al.  Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls , 2016, ESMO Open.

[20]  A. Talhouk,et al.  Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis , 2016, Clinical Cancer Research.

[21]  Jian-jun Wei,et al.  Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases. , 2013, Archives of pathology & laboratory medicine.

[22]  S. Leung,et al.  Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas , 2013, The American journal of surgical pathology.

[23]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[24]  R. Simon,et al.  "Surface epithelial changes" in uterine endometrioid carcinoma mimicking micropapillary serous borderline tumor of ovary: report of two cases and review of the literature , 2011, Diagnostic pathology.

[25]  R. Scully,et al.  Uterine Endometrioid Carcinoma with Small Nonvillous Papillae: An Analysis of 26 Cases of a Favorable-Prognosis Tumor To Be Distinguished from Serous Carcinoma , 2000, International journal of surgical pathology.